Iridex (IRIX) Work In Process (2013 - 2024)
Iridex's quarterly Work In Process came in at $15000.0 in Q3 2024, down 96.53% year-on-year from $432000.0 in Q3 2023, and down 25.0% quarter-over-quarter from $20000.0 in Q2 2024.
Iridex has reported Work In Process for 12 years, with the latest figure at $15000.0 in Q3 2024.
- For the quarter ending Q3 2024, Work In Process fell 96.53% year-over-year to $15000.0; the trailing twelve-month figure through Sep 2024 stood at $15000.0 (down 96.53% YoY), and the FY2023 full-year result was $156000.0, down 51.25% from the prior year.
- Work In Process for Q3 2024 stood at $15000.0, down from $20000.0 in the prior quarter.
- The five-year high for Work In Process was $747000.0 in Q1 2020, with the low at $15000.0 in Q3 2024.
- Average Work In Process over 5 years is $357611.1, with a median of $358500.0 recorded in 2022.
- Year-over-year, Work In Process jumped 59.2% in 2022 and plunged 96.53% in 2024.
- Tracing IRIX's Work In Process over 5 years: stood at $601000.0 in 2020, then tumbled by 30.95% to $415000.0 in 2021, then fell by 22.89% to $320000.0 in 2022, then tumbled by 51.25% to $156000.0 in 2023, then slumped by 90.38% to $15000.0 in 2024.
- The last three Work In Process figures came in at $15000.0 (Q3 2024), $20000.0 (Q2 2024), and $135000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 28, 2024 | 15,000.00 |
| Jun 29, 2024 | 20,000.00 |
| Mar 30, 2024 | 135,000.00 |
| Dec 30, 2023 | 156,000.00 |
| Sep 30, 2023 | 432,000.00 |
| Jul 1, 2023 | 438,000.00 |
| Apr 1, 2023 | 397,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Oct 1, 2022 | 301,000.00 |
| Jul 2, 2022 | 312,000.00 |
| Apr 2, 2022 | 270,000.00 |
| Jan 1, 2022 | 201,000.00 |
| Oct 2, 2021 | 415,000.00 |
| Jul 3, 2021 | 595,000.00 |
| Apr 3, 2021 | 534,000.00 |
| Jan 2, 2021 | 548,000.00 |
| Sep 26, 2020 | 601,000.00 |
| Mar 28, 2020 | 747,000.00 |
| Dec 28, 2019 | 1.11 Mn |
| Sep 28, 2019 | 811,000.00 |
| Jun 29, 2019 | 572,000.00 |
| Mar 30, 2019 | 534,000.00 |
| Dec 29, 2018 | 1.08 Mn |
| Sep 29, 2018 | 824,000.00 |
| Jun 30, 2018 | 1.08 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 30, 2017 | 1.28 Mn |
| Sep 30, 2017 | 1.86 Mn |
| Jul 1, 2017 | 2.07 Mn |
| Apr 1, 2017 | 2.17 Mn |
| Dec 31, 2016 | 2.34 Mn |
| Oct 1, 2016 | 2.72 Mn |
| Jul 2, 2016 | 2.03 Mn |
| Apr 2, 2016 | 2.15 Mn |
| Jan 2, 2016 | 1.79 Mn |
| Oct 3, 2015 | 1.94 Mn |
| Jul 4, 2015 | 2.10 Mn |
| Apr 4, 2015 | 1.83 Mn |
| Jan 3, 2015 | 1.61 Mn |
| Sep 27, 2014 | 1.74 Mn |
| Jun 28, 2014 | 1.46 Mn |
| Mar 29, 2014 | 1.04 Mn |
| Dec 28, 2013 | 976,000.00 |